Machine Learning has been an ongoing focus of FDA activity for some time. The first Industry Discussion Paper on the topic was launched back in 2019, followed by an Action Plan in 2021 aimed at ...
The Transparency Principles emphasize the effective communication of relevant information about a MLMD to users, such as the intended use(s), device development, device performance, and method for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results